We believe that good economic analysis in health care contributes to the welfare of society by allowing access to promising new treatments and informing sound clinical and political decision-making.

 

We know that challenging projects in this field require an experienced, dedicated, and nimble team.

 

We aim to occupy the space between industry, academia and payers by designing elegant and useful solutions for our clients.

 

.......................................................................................................................................................................................................................................

Evidence review and synthesis

What evidence is available in this disease area?

What is the current clinical practice and guidelines for treatment of this disease?

What are the main outcomes and what is my competitors’ efficacy and safety?

Where do we stand against competition on these outcomes?

What is the impact of this disease on patient quality of life?

 

Services:

Literature review of clinical effectiveness, quality of life, economic evidence,

or resource-use

Advice on clinical trial endpoints

Indirect comparison analysis

Pairwise and network meta-analysis

.......................................................................................................................................................................................................................................

Economic evaluation and decision analytic modelling

How do the effects of this intervention translate to quality of life benefits for patients?

What is the cost of this intervention to payers?

How will it affect local budgets?

How do the costs and expected benefits of this intervention compare to those of the competition?

How transferable are cost and effectiveness evidence to my local market?

 

Services

Early stage economic analysis

Global economic model

Model adaptation or extension to other populations/ indications

Budget impact model

Training in economic modelling

.......................................................................................................................................................................................................................................

Reimbursement applications / health technology assessment dossiers

What is the likelihood of reimbursement?

Is the evidence enough for decision makers?

 

Services:

Our presence in the UK and Canada has contributed to in-depth understanding of the requirements for reimbursement in these countries.    We develop submissions for NICE, SMC, CDR and pCODR and advise our clients about the strategy for a successful reimbursement application.

Through our work in the development and adaption of global economic models we have also gained extensive experience in supporting reimbursement submissions in Europe (France, Scandinavia, Germany, etc.), Australia and several countries of East Asia.

.......................................................................................................................................................................................................................................

Effective communication

How can my work influence the success of the product?

What's our publication strategy?

How can we effectively promote the findings of our work?

 

Services:

We support effective communication of our research with scientific publications and presentations in international conferences.

 

Publications

Click for PDF link

Our senior team of researchers Contact us

info@symmetron.net

Our team is located in the UK and Canada

United Kingdom

 

Kinetic Centre

Theobald Street, Elstree

WD6 4PJ

UK

 

Phone: +44 (0) 208 387 1595

Fax: +44 (0) 208 711 6876

Canada

 

Suite 200

20 Camden Street

Toronto  Ontario  M5V 1V1

Canada

 

Phone: +1 (416) 304 9002

Symmetron 2015 Copyright | Design by blackballoon Graphic Design Studio